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Introduction 
Gout is a common inflammatory arthritis caused by 
deposition of monosodium urate (MSU) crystals in 
synovial fluid and other tissues. Hyperuricemia, 
usually related to renal underexcretion, is the 
essential precondition for gout. In advanced or 
untreated gout, tophi (collections of MSU crystals 
with associated inflammation) can form near joints, 
bones, tendons, and the external ear [1]. We present 
a case of disseminated cutaneous gout, a rare 
atypical cutaneous manifestation of gout. 
 
Case Synopsis 
A 50-year-old obese man with a history of colon 
adenocarcinoma and chronic gouty arthritis, 
nonadherent to medication and lifestyle 
interventions, presented to the emergency 
department complaining of worsening redness 
following incision and drainage of a painful skin 
lesion on the left calf. He reported multiple 
additional lesions over his trunk, arms, and legs of 
several years’ duration, as well as chronic diffuse 
arthralgias. He was febrile and tachycardic and was 
found to have leukocytosis (16.2×109/L; normal 
range, 4.5-10.0) with neutrophilic predominance 
(79.4%). Owing to concern for cellulitis, broad-
spectrum antibiotics were initiated and he was 
admitted for further management. Blood and 
superficial wound cultures were negative. Workup 
revealed elevated serum uric acid (9.3mg/dL; normal 
range, 4.0-8.1), which was unchanged from six 
months earlier. X-rays of the upper and lower 
extremities showed arthritic changes, without 
evidence of tophi. A rheumatology consultant 
determined there was no acute gout flare and 
recommended naproxen administration and 
restarting colchicine and febuxostat. As his skin  
Abstract 
Disseminated cutaneous gout is a rare atypical 
cutaneous manifestation of gout in which 
widespread dermal and subcutaneous tophi develop 
at extra-articular body sites. Given the lack of joint 
involvement that is typically a feature in tophaceous 
gout, the diagnosis may not be initially suspected. 
We present the case of a 50-year-old Hispanic man 
with poorly controlled gout who was evaluated for 
several years of firm papulonodules over the trunk 
and upper and lower extremities, sparing the joints; 
histopathology confirmed, the diagnosis of 
disseminated cutaneous gout. Per our literature 
review, disseminated cutaneous gout presents with 
polymorphous papules and nodules that can mimic 
other, more common cutaneous diseases. There is a 
preponderance of cases in males, Asians, and 
patients with longstanding gout. The lower 
extremities are involved in nearly all reports. Uric 
acid-lowering therapy with allopurinol has been 
reported to decrease the size and number of lesions 
in a minority of treated patients. 
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lesions were not typical of gout, dermatologic 
evaluation was recommended.  
Examination was significant for multiple mildly 
tender, erythematous to hyperpigmented, firm 
papulonodules on the bilateral flexor and extensor 
upper and lower extremities and abdomen; no 
lesions were located over joints (Figure 1). During 
the consultation, a family history of colon cancer was 
elicited in the patient’s sister, raising concern for 
pilomatricomas or calcified epidermal inclusion cysts 
associated with Gardner syndrome. Upon punch 
biopsy, there was extrusion of a chalky white  
 
Figure 2. A) Punch biopsy revealed deposition of amorphous 
pink material throughout the mid to deep dermis on low power. 
H&E, 10×. B) High-power image showing extension into the 
subcutaneous septae. H&E, 40×. 
 
Figure 1. Multiple hyperpigmented to erythematous firm 
papulonodules at extra-articular sites on the A) upper and B) 
lower extremities. 
A 
B 
A
B
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substance without malodor. On histopathologic 
examination, there was deposition of amorphous 
pink material throughout the deep dermis extending 
into the subcutaneous septae (Figure 2), consistent 
with gout. A diagnosis of disseminated cutaneous 
gout was made. On follow-up nine months later, 
there was no significant improvement in the 
patient’s skin lesions while on colchicine and 
febuxostat. 
 
Case Discussion 
Disseminated cutaneous gout is a rare cutaneous 
manifestation of gout in which widespread dermal 
and subcutaneous tophi form at extra-articular sites 
[2]. In some instances, the term miliarial gout has 
been used to describe cases featuring diffuse milia-
like papules [3]. Given its varied clinical 
morphologies, the differential diagnosis can also 
include calcinosis cutis, rheumatoid nodules, foreign 
body granulomas, and eruptive xanthomas [4]. The 
pathogenesis is poorly understood. In our review of 
23 reported cases of extensive extra-articular 
dermal/subcutaneous tophi (including the present 
case), [2-18], the majority of patients were male 
(87%) and Asian (57%), (Table 1). There was fairly 
equal representation from Asian countries with 
high gout prevalence (Taiwan) as well as those with 
low prevalence (China, South Korea, Philippines, 
Vietnam), [19]. Only 22% of patients were Hispanic or 
Caucasian (22%). Patients tended to have 
longstanding gout (mean duration 9.5 years) and 
hyperuricemia (83%). The lower extremities were 
most often affected (91%), followed by the upper 
extremities (74%) and trunk (39%). The most 
common comorbidities were chronic kidney disease 
(61%) and hypertension (61%). Notably, in several 
cases, the skin involvement prompted the initial 
diagnosis of gout. 
If possible, biopsies of suspected gout should be 
fixed in absolute alcohol to permit visualization of 
negatively birefringent MSU crystals under polarized 
light [3]. Formalin fixation and hematoxylin-eosin 
staining lead to crystal dissolution, but the diagnosis 
can still be made based on dermal and/or 
subcutaneous deposits of pink amorphous material 
with a surrounding infiltrate of lymphocytes, 
histiocytes, and multinucleated giant cells. 
Uric acid-lowering therapy with allopurinol has been 
reported to decrease the size and number of tophi in 
around one-third of patients with disseminated 
cutaneous gout. However, it is important to inform 
patients that improvement may occur gradually over 
years [4, 16, 18]. Surgical excision could be 
considered for tophi causing nerve compression or 
limiting mobility. All patients should be counseled 
on lifestyle modifications including weight loss and 
dietary trigger avoidance. 
 
Conclusion 
The manifestation of intra-articular tophi in 
advanced gout is general medical knowledge. 
However, disseminated cutaneous gout is a rare  
Table 1. Characteristics of reported patients with disseminated 
cutaneous gout, including present case (N=23), [2-18] 
Characteristic Value 
Age, mean (SD), years 49.1 (10.3) 
Sex  
     Male 20 (87.0) 
     Female 3 (13.0) 
Race/Ethnicity  
     Asian 13 (56.5) 
     Hispanic 3 (13.0) 
     Caucasian 2 (8.7) 
     Not reported 5 (21.7) 
Gout duration, mean (SD), years 9.5 (6.0) 
Hyperuricemia 19 (82.6) 
Affected body site  
     Lower extremities 21 (91.3) 
     Upper extremities 17 (73.9) 
     Trunk 9 (39.1) 
Comorbidity  
     Chronic kidney disease 14 (60.9) 
     Hypertension 14 (60.9) 
     Alcohol use 9 (39.1) 
     Diabetes mellitus 8 (34.8) 
     Obesity 7 (30.4) 
     Psoriasis 4 (17.4) 
Allopurinol treatment 16 (69.6)  
     Complete resolution      1 (6.3) 
     Partial resolution      5 (31.3) 
     No response      1 (6.3) 
     Outcome not available      9 (56.3) 
Volume 26 Number 1| January 2020 
26(1): 4 
 
 
- 4 - 
Dermatology Online Journal  ||  Case Report 
atypical variant that should be included in the 
differential diagnosis of firm papules and nodules 
outside the joints, even in the absence of a known 
history of gout. Disseminated cutaneous gout is 
most commonly reported in males, Asians, and those 
with longstanding gout, and strongly favors the 
lower extremities. If there is suspicion for gout, 
biopsies should be fixed in absolute alcohol to 
permit visualization of monosodium urate crystals  
under polarized light. Allopurinol may lead to 
improvement in a minority of cases. Further studies 
are needed to elucidate the pathophysiology, 
predisposing factors, and optimal therapy of 
disseminated cutaneous gout. 
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